Casdin Capital
Venture Capital
Active
New York, United States
205
98M
149
17.08
16
0.27
41
- Stages of investment
- Areas of investment
Summary
Casdin Capital appeared to be the VC, which was created in 2011. The leading representative office of defined VC is situated in the New York. The company was established in North America in United States.
The fund is constantly included in 2-6 investment rounds annually. This Casdin Capital works on 13 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2018. The typical startup value when the investment from Casdin Capital is more than 1 billion dollars.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Casdin Capital, startups are often financed by The Column Group, ARCH Venture Partners, Topspin Partners. The meaningful sponsors for the fund in investment in the same round are Foresite Capital, Redmile Group, Wellington Management. In the next rounds fund is usually obtained by Redmile Group, Perceptive Advisors, GV.
We also calculated 2 valuable employees in our database.
The fund has no exact preference in some founders of portfolio startups. When startup sums 1 of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Foundation Medicine, Flatiron Health, 23andMe. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 205
- Lead investments
- 16
- Exits
- 41
- Rounds per year
- 17.08
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (163)
- Health Care (108)
- Therapeutics (58)
- Medical (49)
- Life Science (42) Show 50 more
- Investments by region
-
- United States (176)
- United Kingdom (7)
- France (7)
- Switzerland (3)
- Netherlands (2) Show 5 more
- Peak activity year
- 2021
- Number of Unicorns
- 9
- Number of Decacorns
- 10
- Number of Minotaurs
- 5
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 269M
- Group Appearance index
- 0.94
- Avg. company exit year
- 9
- Avg. multiplicator
- 6.10
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Basilard BioTech | 06 Oct 2021 | Biotechnology, Life Science, Biopharma | Seed | United States, California, California | |
Idrx | 02 Aug 2022 | Biotechnology, Life Science, Product Research | Early Stage Venture | 122M |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.